#biotech #RBL LLC #Modi Ventures

RBL LLC Secures Investment from Modi Ventures

On August 8, 2025, RBL LLC, a leading biotech venture creation studio, announced the acquisition of a significant investment from Modi Ventures. This collaboration is aimed at bolstering RBL's ongoing mission to establish and expand disruptive startups within the biotech sector, particularly those focused on groundbreaking medical technologies.

With the investment, RBL is set to facilitate the transformation of innovative ideas into clinical-stage companies, pushing advancements in healthcare and medical treatment. The announcement also included the appointment of Sahir Ali, the founder and general partner of Modi Ventures, to RBL's board of directors. Ali’s role is expected to bridge the existing gap between academic biotechnology discoveries and their application in clinical care, leveraging his extensive expertise in technology and healthcare.

Paul Wotton, managing partner at RBL, emphasized, “This investment by Modi Ventures will be instrumental to RBL's growth as it reinforces confidence in our venture creation model and accelerates our ability to develop successful biotech startups.” The addition of Ali to the board furthers the strategic partnership between RBL and Modi, with expectations that Ali’s guidance will aid in navigating the complexities of biotech innovations.

Ali commented on the collaboration, stating, “The bold thinking and entrepreneurial initiatives coming out of RBL represent an important cornerstone of the rapidly evolving Houston life sciences scene, and I am honored to contribute to this growth by joining this exceptional board.” His new role is aimed at not just fostering company creation but also reshaping patient care to be more effective and collaborative.

Paul Cherukuri, a board member of RBL and chief innovation officer at Rice University, expressed that